“The Georgia Institute of Technology has been selected as the in-depth cell characterization platform hub for the National Institute of Health’s (NIH) Regenerative Medicine Innovation Project (RMIP). Established under the 21st Century Cures Act, the main goal of the $30 million RMIP is the development of transformative new therapies based on adult stem cells.” The Precision Biosystems Lab will play a key role in this hub with the characterization and measurement of epithelial cells. Read more here!